BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 943494 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H18ClN3O2/c1-11-10-12(18)4-5-13(11)14-15(16(22)20-6-2-7-20)19-21-8-3-9-23-17(14)21/h4-5,10H,2-3,6-9H2,1H3 BLUWLSQGJDRYLP-UHFFFAOYSA-N 399921 Azetidin-1-yl[3-(4-chloro-2-methylphenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 1::US10738063, Example 1 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 211 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399921&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366758 405259955 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943495 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H18ClN3O2/c1-11-10-12(18)4-5-13(11)14-15(16(22)20-6-2-7-20)19-21-8-3-9-23-17(14)21/h4-5,10H,2-3,6-9H2,1H3 BLUWLSQGJDRYLP-UHFFFAOYSA-N 399921 Azetidin-1-yl[3-(4-chloro-2-methylphenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 1::US10738063, Example 1 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 241 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399921&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366758 405259955 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943496 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H18ClN3O2/c1-11-10-12(18)4-5-13(11)14-15(16(22)20-6-2-7-20)19-21-8-3-9-23-17(14)21/h4-5,10H,2-3,6-9H2,1H3 BLUWLSQGJDRYLP-UHFFFAOYSA-N 399921 Azetidin-1-yl[3-(4-chloro-2-methylphenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 1::US10738063, Example 1 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 653 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399921&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366758 405259955 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943497 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H18ClN3O2/c1-11-10-12(18)4-5-13(11)14-15(16(22)20-6-2-7-20)19-21-8-3-9-23-17(14)21/h4-5,10H,2-3,6-9H2,1H3 BLUWLSQGJDRYLP-UHFFFAOYSA-N 399921 Azetidin-1-yl[3-(4-chloro-2-methylphenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 1::US10738063, Example 1 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >29800 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399921&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366758 405259955 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943498 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H18ClN3O2/c1-10-9-11(18)3-6-13(10)14-15(16(22)19-12-4-5-12)20-21-7-2-8-23-17(14)21/h3,6,9,12H,2,4-5,7-8H2,1H3,(H,19,22) KXLPTRRQYABNIU-UHFFFAOYSA-N 399922 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 2::US10738063, Example 2 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 219 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399922&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366752 405259956 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943499 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H18ClN3O2/c1-10-9-11(18)3-6-13(10)14-15(16(22)19-12-4-5-12)20-21-7-2-8-23-17(14)21/h3,6,9,12H,2,4-5,7-8H2,1H3,(H,19,22) KXLPTRRQYABNIU-UHFFFAOYSA-N 399922 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 2::US10738063, Example 2 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 120 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399922&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366752 405259956 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943500 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H18ClN3O2/c1-10-9-11(18)3-6-13(10)14-15(16(22)19-12-4-5-12)20-21-7-2-8-23-17(14)21/h3,6,9,12H,2,4-5,7-8H2,1H3,(H,19,22) KXLPTRRQYABNIU-UHFFFAOYSA-N 399922 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 2::US10738063, Example 2 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 368 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399922&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366752 405259956 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943501 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H18ClN3O2/c1-10-9-11(18)3-6-13(10)14-15(16(22)19-12-4-5-12)20-21-7-2-8-23-17(14)21/h3,6,9,12H,2,4-5,7-8H2,1H3,(H,19,22) KXLPTRRQYABNIU-UHFFFAOYSA-N 399922 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 2::US10738063, Example 2 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >29500 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399922&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366752 405259956 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943502 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-8-11(18)9(7-12(10)19)13-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(13)22/h7-8H,1-6H2 LTQPXIUEDFTWNR-UHFFFAOYSA-N 399923 Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 3::US10738063, Example 3 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 27.6 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399923&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366739 405259957 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943503 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-8-11(18)9(7-12(10)19)13-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(13)22/h7-8H,1-6H2 LTQPXIUEDFTWNR-UHFFFAOYSA-N 399923 Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 3::US10738063, Example 3 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 31.9 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399923&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366739 405259957 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943504 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-8-11(18)9(7-12(10)19)13-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(13)22/h7-8H,1-6H2 LTQPXIUEDFTWNR-UHFFFAOYSA-N 399923 Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 3::US10738063, Example 3 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 104 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399923&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366739 405259957 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943505 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-8-11(18)9(7-12(10)19)13-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(13)22/h7-8H,1-6H2 LTQPXIUEDFTWNR-UHFFFAOYSA-N 399923 Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 3::US10738063, Example 3 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >15100 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399923&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366739 405259957 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943506 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)N2CCC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-4-3-9(12(18)13(10)19)11-14(15(23)21-5-1-6-21)20-22-7-2-8-24-16(11)22/h3-4H,1-2,5-8H2 HGOQXTQGKPHGEY-UHFFFAOYSA-N 399924 Azetidin-1-yl[3-(4-chloro-2,3-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 4::US10738063, Example 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 115 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399924&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366734 405259958 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943507 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)N2CCC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-4-3-9(12(18)13(10)19)11-14(15(23)21-5-1-6-21)20-22-7-2-8-24-16(11)22/h3-4H,1-2,5-8H2 HGOQXTQGKPHGEY-UHFFFAOYSA-N 399924 Azetidin-1-yl[3-(4-chloro-2,3-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 4::US10738063, Example 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 248 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399924&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366734 405259958 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943508 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)N2CCC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-4-3-9(12(18)13(10)19)11-14(15(23)21-5-1-6-21)20-22-7-2-8-24-16(11)22/h3-4H,1-2,5-8H2 HGOQXTQGKPHGEY-UHFFFAOYSA-N 399924 Azetidin-1-yl[3-(4-chloro-2,3-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 4::US10738063, Example 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 186 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399924&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366734 405259958 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943509 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)N2CCC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-4-3-9(12(18)13(10)19)11-14(15(23)21-5-1-6-21)20-22-7-2-8-24-16(11)22/h3-4H,1-2,5-8H2 HGOQXTQGKPHGEY-UHFFFAOYSA-N 399924 Azetidin-1-yl[3-(4-chloro-2,3-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 4::US10738063, Example 4 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >17800 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399924&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366734 405259958 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943510 Cc1cc(C#N)c(F)cc1-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C18H17FN4O2/c1-10-7-11(9-20)14(19)8-13(10)15-16(17(24)21-12-3-4-12)22-23-5-2-6-25-18(15)23/h7-8,12H,2-6H2,1H3,(H,21,24) MJHYQMWSWMXYQH-UHFFFAOYSA-N 399925 3-(4-Cyano-5-fluoro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 5::US10738063, Example 5 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 97.4 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399925&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366740 405259959 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943511 Cc1cc(C#N)c(F)cc1-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C18H17FN4O2/c1-10-7-11(9-20)14(19)8-13(10)15-16(17(24)21-12-3-4-12)22-23-5-2-6-25-18(15)23/h7-8,12H,2-6H2,1H3,(H,21,24) MJHYQMWSWMXYQH-UHFFFAOYSA-N 399925 3-(4-Cyano-5-fluoro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 5::US10738063, Example 5 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 34.1 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399925&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366740 405259959 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943512 Cc1cc(C#N)c(F)cc1-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C18H17FN4O2/c1-10-7-11(9-20)14(19)8-13(10)15-16(17(24)21-12-3-4-12)22-23-5-2-6-25-18(15)23/h7-8,12H,2-6H2,1H3,(H,21,24) MJHYQMWSWMXYQH-UHFFFAOYSA-N 399925 3-(4-Cyano-5-fluoro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 5::US10738063, Example 5 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 232 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399925&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366740 405259959 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943513 Cc1cc(C#N)c(F)cc1-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C18H17FN4O2/c1-10-7-11(9-20)14(19)8-13(10)15-16(17(24)21-12-3-4-12)22-23-5-2-6-25-18(15)23/h7-8,12H,2-6H2,1H3,(H,21,24) MJHYQMWSWMXYQH-UHFFFAOYSA-N 399925 3-(4-Cyano-5-fluoro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 5::US10738063, Example 5 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >11900 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399925&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366740 405259959 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943514 Cc1cc(Cl)ccc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23)/t11-/m0/s1 GRFHQTKEAOBDST-NSHDSACASA-N 399926 (6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 6::US10738063, Example 6 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 44.3 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399926&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 137497758 405259960 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943515 Cc1cc(Cl)ccc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23)/t11-/m0/s1 GRFHQTKEAOBDST-NSHDSACASA-N 399926 (6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 6::US10738063, Example 6 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 14.4 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399926&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 137497758 405259960 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943516 Cc1cc(Cl)ccc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23)/t11-/m0/s1 GRFHQTKEAOBDST-NSHDSACASA-N 399926 (6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 6::US10738063, Example 6 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 121 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399926&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 137497758 405259960 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943517 Cc1cc(Cl)ccc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23)/t11-/m0/s1 GRFHQTKEAOBDST-NSHDSACASA-N 399926 (6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 6::US10738063, Example 6 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 4700 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399926&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 137497758 405259960 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943518 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1cc(F)c(Cl)cc1F InChI=1S/C16H13ClF3N3O2/c17-10-4-11(19)9(3-12(10)20)13-14(15(24)21-8-1-2-8)22-23-5-7(18)6-25-16(13)23/h3-4,7-8H,1-2,5-6H2,(H,21,24)/t7-/m0/s1 QMOPFHQOZKALTC-ZETCQYMHSA-N 399927 (6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 7::US10738063, Example 7 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 6.51 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399927&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366728 405259961 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943519 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1cc(F)c(Cl)cc1F InChI=1S/C16H13ClF3N3O2/c17-10-4-11(19)9(3-12(10)20)13-14(15(24)21-8-1-2-8)22-23-5-7(18)6-25-16(13)23/h3-4,7-8H,1-2,5-6H2,(H,21,24)/t7-/m0/s1 QMOPFHQOZKALTC-ZETCQYMHSA-N 399927 (6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 7::US10738063, Example 7 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 2.00 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399927&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366728 405259961 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943520 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1cc(F)c(Cl)cc1F InChI=1S/C16H13ClF3N3O2/c17-10-4-11(19)9(3-12(10)20)13-14(15(24)21-8-1-2-8)22-23-5-7(18)6-25-16(13)23/h3-4,7-8H,1-2,5-6H2,(H,21,24)/t7-/m0/s1 QMOPFHQOZKALTC-ZETCQYMHSA-N 399927 (6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 7::US10738063, Example 7 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 31.4 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399927&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366728 405259961 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943521 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1cc(F)c(Cl)cc1F InChI=1S/C16H13ClF3N3O2/c17-10-4-11(19)9(3-12(10)20)13-14(15(24)21-8-1-2-8)22-23-5-7(18)6-25-16(13)23/h3-4,7-8H,1-2,5-6H2,(H,21,24)/t7-/m0/s1 QMOPFHQOZKALTC-ZETCQYMHSA-N 399927 (6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 7::US10738063, Example 7 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 306 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399927&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366728 405259961 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943522 Cc1cc(Cl)ccc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-9-6-10(18)2-5-12(9)13-14(15(24)21-11-3-4-11)22-23-7-17(19,20)8-25-16(13)23/h2,5-6,11H,3-4,7-8H2,1H3,(H,21,24) RQKJDWFZSBVQSW-UHFFFAOYSA-N 399928 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 8::US10738063, Example 8 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 28.2 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399928&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380356 405259962 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943523 Cc1cc(Cl)ccc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-9-6-10(18)2-5-12(9)13-14(15(24)21-11-3-4-11)22-23-7-17(19,20)8-25-16(13)23/h2,5-6,11H,3-4,7-8H2,1H3,(H,21,24) RQKJDWFZSBVQSW-UHFFFAOYSA-N 399928 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 8::US10738063, Example 8 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 5.29 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399928&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380356 405259962 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943524 Cc1cc(Cl)ccc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-9-6-10(18)2-5-12(9)13-14(15(24)21-11-3-4-11)22-23-7-17(19,20)8-25-16(13)23/h2,5-6,11H,3-4,7-8H2,1H3,(H,21,24) RQKJDWFZSBVQSW-UHFFFAOYSA-N 399928 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 8::US10738063, Example 8 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 67.0 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399928&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380356 405259962 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943525 Cc1cc(Cl)ccc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-9-6-10(18)2-5-12(9)13-14(15(24)21-11-3-4-11)22-23-7-17(19,20)8-25-16(13)23/h2,5-6,11H,3-4,7-8H2,1H3,(H,21,24) RQKJDWFZSBVQSW-UHFFFAOYSA-N 399928 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 8::US10738063, Example 8 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 974 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399928&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380356 405259962 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943526 CC1CCn2nc(C(=O)NC3CC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-21-17(23-10)14(11-2-4-12(18)5-3-11)15(20-21)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) GYVJFOZZFFIUSZ-UHFFFAOYSA-N 399929 3-(4-Chlorophenyl)-N-cyclopropyl-5-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 9::US10738063, Example 9 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 1990 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399929&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380526 405259963 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943527 CC1CCn2nc(C(=O)NC3CC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-21-17(23-10)14(11-2-4-12(18)5-3-11)15(20-21)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) GYVJFOZZFFIUSZ-UHFFFAOYSA-N 399929 3-(4-Chlorophenyl)-N-cyclopropyl-5-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 9::US10738063, Example 9 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 1460 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399929&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380526 405259963 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943528 CC1CCn2nc(C(=O)NC3CC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-21-17(23-10)14(11-2-4-12(18)5-3-11)15(20-21)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) GYVJFOZZFFIUSZ-UHFFFAOYSA-N 399929 3-(4-Chlorophenyl)-N-cyclopropyl-5-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 9::US10738063, Example 9 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 4520 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399929&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380526 405259963 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943529 CC1CCn2nc(C(=O)NC3CC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-21-17(23-10)14(11-2-4-12(18)5-3-11)15(20-21)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) GYVJFOZZFFIUSZ-UHFFFAOYSA-N 399929 3-(4-Chlorophenyl)-N-cyclopropyl-5-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 9::US10738063, Example 9 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 5090 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399929&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380526 405259963 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943530 CC1CCOc2c(c(nn12)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-23-17-14(11-2-4-12(18)5-3-11)15(20-21(10)17)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) ZTEOJNWIHZBBMB-UHFFFAOYSA-N 399930 3-(4-Chlorophenyl)-N-cyclopropyl-7-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 10::US10738063, Example 10 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 4130 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399930&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366732 405259964 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943531 CC1CCOc2c(c(nn12)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-23-17-14(11-2-4-12(18)5-3-11)15(20-21(10)17)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) ZTEOJNWIHZBBMB-UHFFFAOYSA-N 399930 3-(4-Chlorophenyl)-N-cyclopropyl-7-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 10::US10738063, Example 10 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 5570 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399930&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366732 405259964 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943532 CC1CCOc2c(c(nn12)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-23-17-14(11-2-4-12(18)5-3-11)15(20-21(10)17)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) ZTEOJNWIHZBBMB-UHFFFAOYSA-N 399930 3-(4-Chlorophenyl)-N-cyclopropyl-7-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 10::US10738063, Example 10 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 2810 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399930&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366732 405259964 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943533 CC1CCOc2c(c(nn12)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-23-17-14(11-2-4-12(18)5-3-11)15(20-21(10)17)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) ZTEOJNWIHZBBMB-UHFFFAOYSA-N 399930 3-(4-Chlorophenyl)-N-cyclopropyl-7-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 10::US10738063, Example 10 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399930&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366732 405259964 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943534 Fc1cc(ccc1C#N)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c18-13-8-10(2-3-11(13)9-19)14-15(16(23)20-12-4-5-12)21-22-6-1-7-24-17(14)22/h2-3,8,12H,1,4-7H2,(H,20,23) RQCIGHZUMYJCCJ-UHFFFAOYSA-N 399931 3-(4-Cyano-3-fluorophenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 11::US10738063, Example 11 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 972 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399931&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130366747 405259965 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943535 Fc1cc(ccc1C#N)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c18-13-8-10(2-3-11(13)9-19)14-15(16(23)20-12-4-5-12)21-22-6-1-7-24-17(14)22/h2-3,8,12H,1,4-7H2,(H,20,23) RQCIGHZUMYJCCJ-UHFFFAOYSA-N 399931 3-(4-Cyano-3-fluorophenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 11::US10738063, Example 11 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 164 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399931&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130366747 405259965 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943536 Fc1cc(ccc1C#N)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c18-13-8-10(2-3-11(13)9-19)14-15(16(23)20-12-4-5-12)21-22-6-1-7-24-17(14)22/h2-3,8,12H,1,4-7H2,(H,20,23) RQCIGHZUMYJCCJ-UHFFFAOYSA-N 399931 3-(4-Cyano-3-fluorophenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 11::US10738063, Example 11 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 284 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399931&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130366747 405259965 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943537 Fc1cc(ccc1C#N)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c18-13-8-10(2-3-11(13)9-19)14-15(16(23)20-12-4-5-12)21-22-6-1-7-24-17(14)22/h2-3,8,12H,1,4-7H2,(H,20,23) RQCIGHZUMYJCCJ-UHFFFAOYSA-N 399931 3-(4-Cyano-3-fluorophenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 11::US10738063, Example 11 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399931&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130366747 405259965 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943538 Clc1ccc(cc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-2-10(3-5-11)13-14(15(21)18-12-6-7-12)19-20-8-1-9-22-16(13)20/h2-5,12H,1,6-9H2,(H,18,21) NHVPCMGYIPONNR-UHFFFAOYSA-N 399932 US10323042, Example 12::US10738063, Example 12 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 329 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399932&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380451 405259966 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943539 Clc1ccc(cc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-2-10(3-5-11)13-14(15(21)18-12-6-7-12)19-20-8-1-9-22-16(13)20/h2-5,12H,1,6-9H2,(H,18,21) NHVPCMGYIPONNR-UHFFFAOYSA-N 399932 US10323042, Example 12::US10738063, Example 12 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 563 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399932&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380451 405259966 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943540 Clc1ccc(cc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-2-10(3-5-11)13-14(15(21)18-12-6-7-12)19-20-8-1-9-22-16(13)20/h2-5,12H,1,6-9H2,(H,18,21) NHVPCMGYIPONNR-UHFFFAOYSA-N 399932 US10323042, Example 12::US10738063, Example 12 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 511 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399932&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380451 405259966 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943541 Clc1ccc(cc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-2-10(3-5-11)13-14(15(21)18-12-6-7-12)19-20-8-1-9-22-16(13)20/h2-5,12H,1,6-9H2,(H,18,21) NHVPCMGYIPONNR-UHFFFAOYSA-N 399932 US10323042, Example 12::US10738063, Example 12 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >29400 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399932&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380451 405259966 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943542 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) TWKMZYIUVKFGDK-UHFFFAOYSA-N 399933 US10323042, Example 13::US10738063, Example 13 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 57.0 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399933&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380450 405259967 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943543 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) TWKMZYIUVKFGDK-UHFFFAOYSA-N 399933 US10323042, Example 13::US10738063, Example 13 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 50.4 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399933&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380450 405259967 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943544 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) TWKMZYIUVKFGDK-UHFFFAOYSA-N 399933 US10323042, Example 13::US10738063, Example 13 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 71.6 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399933&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380450 405259967 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943545 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) TWKMZYIUVKFGDK-UHFFFAOYSA-N 399933 US10323042, Example 13::US10738063, Example 13 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >16400 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399933&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380450 405259967 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943546 Clc1ccc(cc1Cl)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H15Cl2N3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 OEWWVAVGPPIPRO-UHFFFAOYSA-N 399934 US10323042, Example 14::US10738063, Example 14 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 37.1 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399934&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380453 405259968 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943547 Clc1ccc(cc1Cl)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H15Cl2N3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 OEWWVAVGPPIPRO-UHFFFAOYSA-N 399934 US10323042, Example 14::US10738063, Example 14 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 12700 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399934&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380453 405259968 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943548 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AQWXGANUJJZTGU-UHFFFAOYSA-N 399935 US10323042, Example 15::US10738063, Example 15 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 57.8 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399935&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380527 405259969 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943549 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AQWXGANUJJZTGU-UHFFFAOYSA-N 399935 US10323042, Example 15::US10738063, Example 15 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 92.0 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399935&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380527 405259969 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943550 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AQWXGANUJJZTGU-UHFFFAOYSA-N 399935 US10323042, Example 15::US10738063, Example 15 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 97.0 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399935&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380527 405259969 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943551 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AQWXGANUJJZTGU-UHFFFAOYSA-N 399935 US10323042, Example 15::US10738063, Example 15 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >18300 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399935&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380527 405259969 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943552 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-7-11(18)9(6-12(10)19)13-14(15(23)20-8-2-3-8)21-22-4-1-5-24-16(13)22/h6-8H,1-5H2,(H,20,23) WYSBJUKHVQZOHC-UHFFFAOYSA-N 399936 US10323042, Example 16::US10738063, Example 16 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 46.0 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399936&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380449 405259970 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943553 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-7-11(18)9(6-12(10)19)13-14(15(23)20-8-2-3-8)21-22-4-1-5-24-16(13)22/h6-8H,1-5H2,(H,20,23) WYSBJUKHVQZOHC-UHFFFAOYSA-N 399936 US10323042, Example 16::US10738063, Example 16 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 36.7 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399936&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380449 405259970 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943554 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-7-11(18)9(6-12(10)19)13-14(15(23)20-8-2-3-8)21-22-4-1-5-24-16(13)22/h6-8H,1-5H2,(H,20,23) WYSBJUKHVQZOHC-UHFFFAOYSA-N 399936 US10323042, Example 16::US10738063, Example 16 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 133 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399936&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380449 405259970 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943555 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-7-11(18)9(6-12(10)19)13-14(15(23)20-8-2-3-8)21-22-4-1-5-24-16(13)22/h6-8H,1-5H2,(H,20,23) WYSBJUKHVQZOHC-UHFFFAOYSA-N 399936 US10323042, Example 16::US10738063, Example 16 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >6810 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399936&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380449 405259970 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943556 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-7-12(18)13(19)8-11(9)14-15(16(23)20-10-3-4-10)21-22-5-2-6-24-17(14)22/h7-8,10H,2-6H2,1H3,(H,20,23) AIIYPFJZLRJGEL-UHFFFAOYSA-N 399937 US10323042, Example 17::US10738063, Example 17 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 21.3 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399937&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380483 405259971 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943557 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-7-12(18)13(19)8-11(9)14-15(16(23)20-10-3-4-10)21-22-5-2-6-24-17(14)22/h7-8,10H,2-6H2,1H3,(H,20,23) AIIYPFJZLRJGEL-UHFFFAOYSA-N 399937 US10323042, Example 17::US10738063, Example 17 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 11.0 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399937&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380483 405259971 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943558 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-7-12(18)13(19)8-11(9)14-15(16(23)20-10-3-4-10)21-22-5-2-6-24-17(14)22/h7-8,10H,2-6H2,1H3,(H,20,23) AIIYPFJZLRJGEL-UHFFFAOYSA-N 399937 US10323042, Example 17::US10738063, Example 17 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 89.0 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399937&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380483 405259971 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943559 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-7-12(18)13(19)8-11(9)14-15(16(23)20-10-3-4-10)21-22-5-2-6-24-17(14)22/h7-8,10H,2-6H2,1H3,(H,20,23) AIIYPFJZLRJGEL-UHFFFAOYSA-N 399937 US10323042, Example 17::US10738063, Example 17 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 4830 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399937&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380483 405259971 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943560 Cc1cc(C#N)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C18H17FN4O2/c1-11-8-12(10-20)14(19)9-13(11)15-16(17(24)22-4-2-5-22)21-23-6-3-7-25-18(15)23/h8-9H,2-7H2,1H3 HXVNESZNUYSKMT-UHFFFAOYSA-N 399938 US10323042, Example 18::US10738063, Example 18 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 40.9 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399938&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380529 405259972 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943561 Cc1cc(C#N)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C18H17FN4O2/c1-11-8-12(10-20)14(19)9-13(11)15-16(17(24)22-4-2-5-22)21-23-6-3-7-25-18(15)23/h8-9H,2-7H2,1H3 HXVNESZNUYSKMT-UHFFFAOYSA-N 399938 US10323042, Example 18::US10738063, Example 18 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 23.8 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399938&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380529 405259972 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943562 Cc1cc(C#N)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C18H17FN4O2/c1-11-8-12(10-20)14(19)9-13(11)15-16(17(24)22-4-2-5-22)21-23-6-3-7-25-18(15)23/h8-9H,2-7H2,1H3 HXVNESZNUYSKMT-UHFFFAOYSA-N 399938 US10323042, Example 18::US10738063, Example 18 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 136 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399938&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380529 405259972 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943563 Cc1cc(C#N)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C18H17FN4O2/c1-11-8-12(10-20)14(19)9-13(11)15-16(17(24)22-4-2-5-22)21-23-6-3-7-25-18(15)23/h8-9H,2-7H2,1H3 HXVNESZNUYSKMT-UHFFFAOYSA-N 399938 US10323042, Example 18::US10738063, Example 18 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 6300 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399938&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380529 405259972 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943564 FC1(F)COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C16H13Cl2F2N3O2/c17-10-4-1-8(5-11(10)18)12-13(14(24)21-9-2-3-9)22-23-6-16(19,20)7-25-15(12)23/h1,4-5,9H,2-3,6-7H2,(H,21,24) BDZYIKRXVZUNQN-UHFFFAOYSA-N 457788 US10738063, Example 19 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 67.8 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457788&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 155884349 440973479 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943565 FC1(F)COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C16H13Cl2F2N3O2/c17-10-4-1-8(5-11(10)18)12-13(14(24)21-9-2-3-9)22-23-6-16(19,20)7-25-15(12)23/h1,4-5,9H,2-3,6-7H2,(H,21,24) BDZYIKRXVZUNQN-UHFFFAOYSA-N 457788 US10738063, Example 19 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 32.9 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457788&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 155884349 440973479 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943566 FC1(F)COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C16H13Cl2F2N3O2/c17-10-4-1-8(5-11(10)18)12-13(14(24)21-9-2-3-9)22-23-6-16(19,20)7-25-15(12)23/h1,4-5,9H,2-3,6-7H2,(H,21,24) BDZYIKRXVZUNQN-UHFFFAOYSA-N 457788 US10738063, Example 19 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 69.5 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457788&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 155884349 440973479 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943567 FC1(F)COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C16H13Cl2F2N3O2/c17-10-4-1-8(5-11(10)18)12-13(14(24)21-9-2-3-9)22-23-6-16(19,20)7-25-15(12)23/h1,4-5,9H,2-3,6-7H2,(H,21,24) BDZYIKRXVZUNQN-UHFFFAOYSA-N 457788 US10738063, Example 19 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 3080 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457788&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 155884349 440973479 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943568 CC1CCn2nc(C(=O)N3CCC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-11-7-10-21-17(23-11)14(12-3-5-13(18)6-4-12)15(19-21)16(22)20-8-2-9-20/h3-6,11H,2,7-10H2,1H3 MONOEYMRTNNARV-UHFFFAOYSA-N 399940 US10323042, Example 20::US10738063, Example 20 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 2970 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399940&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380454 405259974 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943569 CC1CCn2nc(C(=O)N3CCC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-11-7-10-21-17(23-11)14(12-3-5-13(18)6-4-12)15(19-21)16(22)20-8-2-9-20/h3-6,11H,2,7-10H2,1H3 MONOEYMRTNNARV-UHFFFAOYSA-N 399940 US10323042, Example 20::US10738063, Example 20 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 11800 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399940&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380454 405259974 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943570 CC1CCn2nc(C(=O)N3CCC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-11-7-10-21-17(23-11)14(12-3-5-13(18)6-4-12)15(19-21)16(22)20-8-2-9-20/h3-6,11H,2,7-10H2,1H3 MONOEYMRTNNARV-UHFFFAOYSA-N 399940 US10323042, Example 20::US10738063, Example 20 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL >17000 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399940&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380454 405259974 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943571 CC1CCn2nc(C(=O)N3CCC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-11-7-10-21-17(23-11)14(12-3-5-13(18)6-4-12)15(19-21)16(22)20-8-2-9-20/h3-6,11H,2,7-10H2,1H3 MONOEYMRTNNARV-UHFFFAOYSA-N 399940 US10323042, Example 20::US10738063, Example 20 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399940&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380454 405259974 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943572 Clc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15Cl2N3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) XMTOCICLPIPODV-UHFFFAOYSA-N 399941 US10323042, Example 21::US10738063, Example 21 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 90.9 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399941&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380455 405259975 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943573 Clc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15Cl2N3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) XMTOCICLPIPODV-UHFFFAOYSA-N 399941 US10323042, Example 21::US10738063, Example 21 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 103 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399941&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380455 405259975 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943574 Clc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15Cl2N3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) XMTOCICLPIPODV-UHFFFAOYSA-N 399941 US10323042, Example 21::US10738063, Example 21 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 126 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399941&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380455 405259975 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943575 Clc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15Cl2N3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) XMTOCICLPIPODV-UHFFFAOYSA-N 399941 US10323042, Example 21::US10738063, Example 21 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >9700 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399941&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380455 405259975 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943576 Clc1ccc(cc1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-3-11(4-6-12)13-14(15(21)19-7-1-8-19)18-20-9-2-10-22-16(13)20/h3-6H,1-2,7-10H2 BKTUIOVWODWFPG-UHFFFAOYSA-N 399942 US10323042, Example 22::US10738063, Example 22 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 483 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399942&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380473 405259976 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943577 Clc1ccc(cc1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-3-11(4-6-12)13-14(15(21)19-7-1-8-19)18-20-9-2-10-22-16(13)20/h3-6H,1-2,7-10H2 BKTUIOVWODWFPG-UHFFFAOYSA-N 399942 US10323042, Example 22::US10738063, Example 22 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 877 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399942&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380473 405259976 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943578 Clc1ccc(cc1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-3-11(4-6-12)13-14(15(21)19-7-1-8-19)18-20-9-2-10-22-16(13)20/h3-6H,1-2,7-10H2 BKTUIOVWODWFPG-UHFFFAOYSA-N 399942 US10323042, Example 22::US10738063, Example 22 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 977 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399942&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380473 405259976 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943579 Clc1ccc(cc1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-3-11(4-6-12)13-14(15(21)19-7-1-8-19)18-20-9-2-10-22-16(13)20/h3-6H,1-2,7-10H2 BKTUIOVWODWFPG-UHFFFAOYSA-N 399942 US10323042, Example 22::US10738063, Example 22 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399942&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380473 405259976 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943580 Fc1cc(cc(F)c1C#N)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H14F2N4O2/c18-12-7-10(8-13(19)11(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 JVQZYDGQUZXTDQ-UHFFFAOYSA-N 399943 US10323042, Example 23::US10738063, Example 23 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 173 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399943&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380477 405259977 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943581 Fc1cc(cc(F)c1C#N)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H14F2N4O2/c18-12-7-10(8-13(19)11(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 JVQZYDGQUZXTDQ-UHFFFAOYSA-N 399943 US10323042, Example 23::US10738063, Example 23 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 305 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399943&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380477 405259977 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943582 Fc1cc(cc(F)c1C#N)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H14F2N4O2/c18-12-7-10(8-13(19)11(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 JVQZYDGQUZXTDQ-UHFFFAOYSA-N 399943 US10323042, Example 23::US10738063, Example 23 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 770 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399943&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380477 405259977 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943583 Fc1cc(cc(F)c1C#N)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H14F2N4O2/c18-12-7-10(8-13(19)11(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 JVQZYDGQUZXTDQ-UHFFFAOYSA-N 399943 US10323042, Example 23::US10738063, Example 23 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >21400 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399943&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380477 405259977 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943584 COc1c(F)cc(cc1F)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17F2N3O3/c1-24-15-11(18)8-10(9-12(15)19)13-14(16(23)21-4-2-5-21)20-22-6-3-7-25-17(13)22/h8-9H,2-7H2,1H3 ARADJHAPDWYDIE-UHFFFAOYSA-N 399944 US10323042, Example 24::US10738063, Example 24 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 393 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399944&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380471 405259978 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943585 COc1c(F)cc(cc1F)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17F2N3O3/c1-24-15-11(18)8-10(9-12(15)19)13-14(16(23)21-4-2-5-21)20-22-6-3-7-25-17(13)22/h8-9H,2-7H2,1H3 ARADJHAPDWYDIE-UHFFFAOYSA-N 399944 US10323042, Example 24::US10738063, Example 24 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 681 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399944&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380471 405259978 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943586 COc1c(F)cc(cc1F)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17F2N3O3/c1-24-15-11(18)8-10(9-12(15)19)13-14(16(23)21-4-2-5-21)20-22-6-3-7-25-17(13)22/h8-9H,2-7H2,1H3 ARADJHAPDWYDIE-UHFFFAOYSA-N 399944 US10323042, Example 24::US10738063, Example 24 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 421 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399944&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380471 405259978 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943587 COc1c(F)cc(cc1F)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17F2N3O3/c1-24-15-11(18)8-10(9-12(15)19)13-14(16(23)21-4-2-5-21)20-22-6-3-7-25-17(13)22/h8-9H,2-7H2,1H3 ARADJHAPDWYDIE-UHFFFAOYSA-N 399944 US10323042, Example 24::US10738063, Example 24 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399944&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380471 405259978 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943588 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ncnn2c1 InChI=1S/C16H16N6O2/c23-15(19-11-3-4-11)14-13(16-21(20-14)6-1-7-24-16)10-2-5-12-17-9-18-22(12)8-10/h2,5,8-9,11H,1,3-4,6-7H2,(H,19,23) AEPRWSVYIWUKRK-UHFFFAOYSA-N 399945 US10323042, Example 25::US10738063, Example 25 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 2080 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399945&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380475 405259979 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943589 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ncnn2c1 InChI=1S/C16H16N6O2/c23-15(19-11-3-4-11)14-13(16-21(20-14)6-1-7-24-16)10-2-5-12-17-9-18-22(12)8-10/h2,5,8-9,11H,1,3-4,6-7H2,(H,19,23) AEPRWSVYIWUKRK-UHFFFAOYSA-N 399945 US10323042, Example 25::US10738063, Example 25 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 4370 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399945&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380475 405259979 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943590 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ncnn2c1 InChI=1S/C16H16N6O2/c23-15(19-11-3-4-11)14-13(16-21(20-14)6-1-7-24-16)10-2-5-12-17-9-18-22(12)8-10/h2,5,8-9,11H,1,3-4,6-7H2,(H,19,23) AEPRWSVYIWUKRK-UHFFFAOYSA-N 399945 US10323042, Example 25::US10738063, Example 25 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 2620 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399945&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380475 405259979 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943591 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ncnn2c1 InChI=1S/C16H16N6O2/c23-15(19-11-3-4-11)14-13(16-21(20-14)6-1-7-24-16)10-2-5-12-17-9-18-22(12)8-10/h2,5,8-9,11H,1,3-4,6-7H2,(H,19,23) AEPRWSVYIWUKRK-UHFFFAOYSA-N 399945 US10323042, Example 25::US10738063, Example 25 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399945&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380475 405259979 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943592 Cc1cc(ccc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-9-12(10-19)3-6-14(11)15-16(17(23)20-13-4-5-13)21-22-7-2-8-24-18(15)22/h3,6,9,13H,2,4-5,7-8H2,1H3,(H,20,23) MGICYBWWARAATG-UHFFFAOYSA-N 399946 US10323042, Example 26::US10738063, Example 26 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 1650 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399946&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380476 405259980 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943593 Cc1cc(ccc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-9-12(10-19)3-6-14(11)15-16(17(23)20-13-4-5-13)21-22-7-2-8-24-18(15)22/h3,6,9,13H,2,4-5,7-8H2,1H3,(H,20,23) MGICYBWWARAATG-UHFFFAOYSA-N 399946 US10323042, Example 26::US10738063, Example 26 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 4290 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399946&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380476 405259980 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943594 Cc1cc(ccc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-9-12(10-19)3-6-14(11)15-16(17(23)20-13-4-5-13)21-22-7-2-8-24-18(15)22/h3,6,9,13H,2,4-5,7-8H2,1H3,(H,20,23) MGICYBWWARAATG-UHFFFAOYSA-N 399946 US10323042, Example 26::US10738063, Example 26 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 7310 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399946&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380476 405259980 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943595 Cc1cc(ccc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-9-12(10-19)3-6-14(11)15-16(17(23)20-13-4-5-13)21-22-7-2-8-24-18(15)22/h3,6,9,13H,2,4-5,7-8H2,1H3,(H,20,23) MGICYBWWARAATG-UHFFFAOYSA-N 399946 US10323042, Example 26::US10738063, Example 26 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399946&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380476 405259980 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943596 FC(F)Oc1cc(ccn1)-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C16H16F2N4O3/c17-16(18)25-11-8-9(4-5-19-11)12-13(14(23)20-10-2-3-10)21-22-6-1-7-24-15(12)22/h4-5,8,10,16H,1-3,6-7H2,(H,20,23) MYBATSJXBUMOOH-UHFFFAOYSA-N 399947 US10323042, Example 27::US10738063, Example 27 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 178 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399947&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380472 405259981 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943597 FC(F)Oc1cc(ccn1)-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C16H16F2N4O3/c17-16(18)25-11-8-9(4-5-19-11)12-13(14(23)20-10-2-3-10)21-22-6-1-7-24-15(12)22/h4-5,8,10,16H,1-3,6-7H2,(H,20,23) MYBATSJXBUMOOH-UHFFFAOYSA-N 399947 US10323042, Example 27::US10738063, Example 27 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 115 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399947&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380472 405259981 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943598 FC(F)Oc1cc(ccn1)-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C16H16F2N4O3/c17-16(18)25-11-8-9(4-5-19-11)12-13(14(23)20-10-2-3-10)21-22-6-1-7-24-15(12)22/h4-5,8,10,16H,1-3,6-7H2,(H,20,23) MYBATSJXBUMOOH-UHFFFAOYSA-N 399947 US10323042, Example 27::US10738063, Example 27 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 389 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399947&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380472 405259981 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943599 FC(F)Oc1cc(ccn1)-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C16H16F2N4O3/c17-16(18)25-11-8-9(4-5-19-11)12-13(14(23)20-10-2-3-10)21-22-6-1-7-24-15(12)22/h4-5,8,10,16H,1-3,6-7H2,(H,20,23) MYBATSJXBUMOOH-UHFFFAOYSA-N 399947 US10323042, Example 27::US10738063, Example 27 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >12800 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399947&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380472 405259981 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943600 Fc1ccc(cc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C17H15FN4O2/c18-13-5-2-10(9-19)8-12(13)14-15(16(23)20-11-3-4-11)21-22-6-1-7-24-17(14)22/h2,5,8,11H,1,3-4,6-7H2,(H,20,23) QQMQNXMQOPTOHL-UHFFFAOYSA-N 399948 US10323042, Example 28::US10738063, Example 28 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 1320 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399948&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380504 405259982 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943601 Fc1ccc(cc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C17H15FN4O2/c18-13-5-2-10(9-19)8-12(13)14-15(16(23)20-11-3-4-11)21-22-6-1-7-24-17(14)22/h2,5,8,11H,1,3-4,6-7H2,(H,20,23) QQMQNXMQOPTOHL-UHFFFAOYSA-N 399948 US10323042, Example 28::US10738063, Example 28 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399948&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380504 405259982 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943602 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ccnn2c1 InChI=1S/C17H17N5O2/c23-16(19-12-3-4-12)15-14(17-21(20-15)8-1-9-24-17)11-2-5-13-6-7-18-22(13)10-11/h2,5-7,10,12H,1,3-4,8-9H2,(H,19,23) ONZFTFUFKHZXEF-UHFFFAOYSA-N 399949 US10323042, Example 29::US10738063, Example 29 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 3090 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399949&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380501 405259983 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943603 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ccnn2c1 InChI=1S/C17H17N5O2/c23-16(19-12-3-4-12)15-14(17-21(20-15)8-1-9-24-17)11-2-5-13-6-7-18-22(13)10-11/h2,5-7,10,12H,1,3-4,8-9H2,(H,19,23) ONZFTFUFKHZXEF-UHFFFAOYSA-N 399949 US10323042, Example 29::US10738063, Example 29 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 2190 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399949&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380501 405259983 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943604 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ccnn2c1 InChI=1S/C17H17N5O2/c23-16(19-12-3-4-12)15-14(17-21(20-15)8-1-9-24-17)11-2-5-13-6-7-18-22(13)10-11/h2,5-7,10,12H,1,3-4,8-9H2,(H,19,23) ONZFTFUFKHZXEF-UHFFFAOYSA-N 399949 US10323042, Example 29::US10738063, Example 29 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 4340 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399949&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380501 405259983 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943605 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ccnn2c1 InChI=1S/C17H17N5O2/c23-16(19-12-3-4-12)15-14(17-21(20-15)8-1-9-24-17)11-2-5-13-6-7-18-22(13)10-11/h2,5-7,10,12H,1,3-4,8-9H2,(H,19,23) ONZFTFUFKHZXEF-UHFFFAOYSA-N 399949 US10323042, Example 29::US10738063, Example 29 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399949&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380501 405259983 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943606 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-7-11(13(19)6-9(12)8-20)14-15(16(24)21-10-2-3-10)22-23-4-1-5-25-17(14)23/h6-7,10H,1-5H2,(H,21,24) KEZOJFATBPGWGR-UHFFFAOYSA-N 399950 US10323042, Example 30::US10738063, Example 30 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 166 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399950&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380499 405259984 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943607 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-7-11(13(19)6-9(12)8-20)14-15(16(24)21-10-2-3-10)22-23-4-1-5-25-17(14)23/h6-7,10H,1-5H2,(H,21,24) KEZOJFATBPGWGR-UHFFFAOYSA-N 399950 US10323042, Example 30::US10738063, Example 30 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 593 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399950&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380499 405259984 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943608 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-7-11(13(19)6-9(12)8-20)14-15(16(24)21-10-2-3-10)22-23-4-1-5-25-17(14)23/h6-7,10H,1-5H2,(H,21,24) KEZOJFATBPGWGR-UHFFFAOYSA-N 399950 US10323042, Example 30::US10738063, Example 30 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 257 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399950&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380499 405259984 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943609 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-7-11(13(19)6-9(12)8-20)14-15(16(24)21-10-2-3-10)22-23-4-1-5-25-17(14)23/h6-7,10H,1-5H2,(H,21,24) KEZOJFATBPGWGR-UHFFFAOYSA-N 399950 US10323042, Example 30::US10738063, Example 30 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >17900 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399950&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380499 405259984 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943610 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc(nc1)C#N InChI=1S/C16H15N5O2/c17-8-12-3-2-10(9-18-12)13-14(15(22)19-11-4-5-11)20-21-6-1-7-23-16(13)21/h2-3,9,11H,1,4-7H2,(H,19,22) WAMLUDBFCUDTPT-UHFFFAOYSA-N 399951 US10323042, Example 31::US10738063, Example 31 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 1150 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399951&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380500 405259985 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943611 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc(nc1)C#N InChI=1S/C16H15N5O2/c17-8-12-3-2-10(9-18-12)13-14(15(22)19-11-4-5-11)20-21-6-1-7-23-16(13)21/h2-3,9,11H,1,4-7H2,(H,19,22) WAMLUDBFCUDTPT-UHFFFAOYSA-N 399951 US10323042, Example 31::US10738063, Example 31 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399951&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380500 405259985 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943612 Clc1cccc(c1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-1-4-11(10-12)13-14(15(21)19-6-2-7-19)18-20-8-3-9-22-16(13)20/h1,4-5,10H,2-3,6-9H2 CRKMXHLUZCJURN-UHFFFAOYSA-N 399952 US10323042, Example 32::US10738063, Example 32 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 207 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399952&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380505 405259986 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943613 Clc1cccc(c1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-1-4-11(10-12)13-14(15(21)19-6-2-7-19)18-20-8-3-9-22-16(13)20/h1,4-5,10H,2-3,6-9H2 CRKMXHLUZCJURN-UHFFFAOYSA-N 399952 US10323042, Example 32::US10738063, Example 32 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 188 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399952&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380505 405259986 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943614 Clc1cccc(c1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-1-4-11(10-12)13-14(15(21)19-6-2-7-19)18-20-8-3-9-22-16(13)20/h1,4-5,10H,2-3,6-9H2 CRKMXHLUZCJURN-UHFFFAOYSA-N 399952 US10323042, Example 32::US10738063, Example 32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 48.2 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399952&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380505 405259986 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943615 Clc1cccc(c1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-1-4-11(10-12)13-14(15(21)19-6-2-7-19)18-20-8-3-9-22-16(13)20/h1,4-5,10H,2-3,6-9H2 CRKMXHLUZCJURN-UHFFFAOYSA-N 399952 US10323042, Example 32::US10738063, Example 32 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >12200 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399952&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380505 405259986 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943616 Clc1cccc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-1-3-10(9-11)13-14(15(21)18-12-5-6-12)19-20-7-2-8-22-16(13)20/h1,3-4,9,12H,2,5-8H2,(H,18,21) GBWMEFKBLUNZIM-UHFFFAOYSA-N 399953 US10323042, Example 33::US10738063, Example 33 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 1080 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399953&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380503 405259987 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943617 Clc1cccc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-1-3-10(9-11)13-14(15(21)18-12-5-6-12)19-20-7-2-8-22-16(13)20/h1,3-4,9,12H,2,5-8H2,(H,18,21) GBWMEFKBLUNZIM-UHFFFAOYSA-N 399953 US10323042, Example 33::US10738063, Example 33 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 276 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399953&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380503 405259987 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943618 Clc1cccc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-1-3-10(9-11)13-14(15(21)18-12-5-6-12)19-20-7-2-8-22-16(13)20/h1,3-4,9,12H,2,5-8H2,(H,18,21) GBWMEFKBLUNZIM-UHFFFAOYSA-N 399953 US10323042, Example 33::US10738063, Example 33 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 450 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399953&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380503 405259987 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943619 Clc1cccc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-1-3-10(9-11)13-14(15(21)18-12-5-6-12)19-20-7-2-8-22-16(13)20/h1,3-4,9,12H,2,5-8H2,(H,18,21) GBWMEFKBLUNZIM-UHFFFAOYSA-N 399953 US10323042, Example 33::US10738063, Example 33 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >29000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399953&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380503 405259987 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943620 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H17ClFN3O2/c1-9(2)19-15(22)14-13(10-4-5-11(17)12(18)8-10)16-21(20-14)6-3-7-23-16/h4-5,8-9H,3,6-7H2,1-2H3,(H,19,22) SPFPGSNCBFECSG-UHFFFAOYSA-N 399954 US10323042, Example 34::US10738063, Example 34 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 979 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399954&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380502 405259988 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943621 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H17ClFN3O2/c1-9(2)19-15(22)14-13(10-4-5-11(17)12(18)8-10)16-21(20-14)6-3-7-23-16/h4-5,8-9H,3,6-7H2,1-2H3,(H,19,22) SPFPGSNCBFECSG-UHFFFAOYSA-N 399954 US10323042, Example 34::US10738063, Example 34 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 220 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399954&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380502 405259988 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943622 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H17ClFN3O2/c1-9(2)19-15(22)14-13(10-4-5-11(17)12(18)8-10)16-21(20-14)6-3-7-23-16/h4-5,8-9H,3,6-7H2,1-2H3,(H,19,22) SPFPGSNCBFECSG-UHFFFAOYSA-N 399954 US10323042, Example 34::US10738063, Example 34 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 1210 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399954&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380502 405259988 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943623 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H17ClFN3O2/c1-9(2)19-15(22)14-13(10-4-5-11(17)12(18)8-10)16-21(20-14)6-3-7-23-16/h4-5,8-9H,3,6-7H2,1-2H3,(H,19,22) SPFPGSNCBFECSG-UHFFFAOYSA-N 399954 US10323042, Example 34::US10738063, Example 34 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 18700 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399954&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380502 405259988 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943624 CNC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C14H13ClFN3O2/c1-17-13(20)12-11(8-3-4-9(15)10(16)7-8)14-19(18-12)5-2-6-21-14/h3-4,7H,2,5-6H2,1H3,(H,17,20) KPTCNORYAGZPTM-UHFFFAOYSA-N 399955 US10323042, Example 35::US10738063, Example 35 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 2300 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399955&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380361 405259989 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943625 CNC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C14H13ClFN3O2/c1-17-13(20)12-11(8-3-4-9(15)10(16)7-8)14-19(18-12)5-2-6-21-14/h3-4,7H,2,5-6H2,1H3,(H,17,20) KPTCNORYAGZPTM-UHFFFAOYSA-N 399955 US10323042, Example 35::US10738063, Example 35 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 933 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399955&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380361 405259989 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943626 CNC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C14H13ClFN3O2/c1-17-13(20)12-11(8-3-4-9(15)10(16)7-8)14-19(18-12)5-2-6-21-14/h3-4,7H,2,5-6H2,1H3,(H,17,20) KPTCNORYAGZPTM-UHFFFAOYSA-N 399955 US10323042, Example 35::US10738063, Example 35 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 1470 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399955&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380361 405259989 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943627 CNC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C14H13ClFN3O2/c1-17-13(20)12-11(8-3-4-9(15)10(16)7-8)14-19(18-12)5-2-6-21-14/h3-4,7H,2,5-6H2,1H3,(H,17,20) KPTCNORYAGZPTM-UHFFFAOYSA-N 399955 US10323042, Example 35::US10738063, Example 35 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >23200 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399955&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380361 405259989 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943628 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(cc1C)C#N InChI=1S/C17H17FN4O2/c1-3-20-16(23)15-14(17-22(21-15)5-4-6-24-17)12-8-13(18)11(9-19)7-10(12)2/h7-8H,3-6H2,1-2H3,(H,20,23) GWWNXYAZKUJVBF-UHFFFAOYSA-N 399956 US10323042, Example 36::US10738063, Example 36 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 838 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399956&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380362 405259990 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943629 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(cc1C)C#N InChI=1S/C17H17FN4O2/c1-3-20-16(23)15-14(17-22(21-15)5-4-6-24-17)12-8-13(18)11(9-19)7-10(12)2/h7-8H,3-6H2,1-2H3,(H,20,23) GWWNXYAZKUJVBF-UHFFFAOYSA-N 399956 US10323042, Example 36::US10738063, Example 36 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 56.0 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399956&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380362 405259990 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943630 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(cc1C)C#N InChI=1S/C17H17FN4O2/c1-3-20-16(23)15-14(17-22(21-15)5-4-6-24-17)12-8-13(18)11(9-19)7-10(12)2/h7-8H,3-6H2,1-2H3,(H,20,23) GWWNXYAZKUJVBF-UHFFFAOYSA-N 399956 US10323042, Example 36::US10738063, Example 36 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 450 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399956&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380362 405259990 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943631 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(cc1C)C#N InChI=1S/C17H17FN4O2/c1-3-20-16(23)15-14(17-22(21-15)5-4-6-24-17)12-8-13(18)11(9-19)7-10(12)2/h7-8H,3-6H2,1-2H3,(H,20,23) GWWNXYAZKUJVBF-UHFFFAOYSA-N 399956 US10323042, Example 36::US10738063, Example 36 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >20700 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399956&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380362 405259990 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943632 CNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C15H15ClFN3O2/c1-8-6-10(16)11(17)7-9(8)12-13(14(21)18-2)19-20-4-3-5-22-15(12)20/h6-7H,3-5H2,1-2H3,(H,18,21) XWLDNGLNMIBYMP-UHFFFAOYSA-N 399957 US10323042, Example 37::US10738063, Example 37 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 918 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399957&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380359 405259991 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943633 CNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C15H15ClFN3O2/c1-8-6-10(16)11(17)7-9(8)12-13(14(21)18-2)19-20-4-3-5-22-15(12)20/h6-7H,3-5H2,1-2H3,(H,18,21) XWLDNGLNMIBYMP-UHFFFAOYSA-N 399957 US10323042, Example 37::US10738063, Example 37 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 363 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399957&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380359 405259991 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943634 CNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C15H15ClFN3O2/c1-8-6-10(16)11(17)7-9(8)12-13(14(21)18-2)19-20-4-3-5-22-15(12)20/h6-7H,3-5H2,1-2H3,(H,18,21) XWLDNGLNMIBYMP-UHFFFAOYSA-N 399957 US10323042, Example 37::US10738063, Example 37 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 854 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399957&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380359 405259991 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943635 CNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C15H15ClFN3O2/c1-8-6-10(16)11(17)7-9(8)12-13(14(21)18-2)19-20-4-3-5-22-15(12)20/h6-7H,3-5H2,1-2H3,(H,18,21) XWLDNGLNMIBYMP-UHFFFAOYSA-N 399957 US10323042, Example 37::US10738063, Example 37 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 11800 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399957&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380359 405259991 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943636 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C16H17ClFN3O2/c1-3-19-15(22)14-13(16-21(20-14)5-4-6-23-16)10-8-12(18)11(17)7-9(10)2/h7-8H,3-6H2,1-2H3,(H,19,22) WYVVCFNADZMHEN-UHFFFAOYSA-N 399958 US10323042, Example 38::US10738063, Example 38 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 168 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399958&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380363 405259992 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943637 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C16H17ClFN3O2/c1-3-19-15(22)14-13(16-21(20-14)5-4-6-23-16)10-8-12(18)11(17)7-9(10)2/h7-8H,3-6H2,1-2H3,(H,19,22) WYVVCFNADZMHEN-UHFFFAOYSA-N 399958 US10323042, Example 38::US10738063, Example 38 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 26.2 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399958&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380363 405259992 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943638 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C16H17ClFN3O2/c1-3-19-15(22)14-13(16-21(20-14)5-4-6-23-16)10-8-12(18)11(17)7-9(10)2/h7-8H,3-6H2,1-2H3,(H,19,22) WYVVCFNADZMHEN-UHFFFAOYSA-N 399958 US10323042, Example 38::US10738063, Example 38 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 152 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399958&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380363 405259992 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943639 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C16H17ClFN3O2/c1-3-19-15(22)14-13(16-21(20-14)5-4-6-23-16)10-8-12(18)11(17)7-9(10)2/h7-8H,3-6H2,1-2H3,(H,19,22) WYVVCFNADZMHEN-UHFFFAOYSA-N 399958 US10323042, Example 38::US10738063, Example 38 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 3570 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399958&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380363 405259992 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943640 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1F InChI=1S/C15H14ClF2N3O2/c1-2-19-14(22)13-12(15-21(20-13)4-3-5-23-15)8-6-11(18)9(16)7-10(8)17/h6-7H,2-5H2,1H3,(H,19,22) MYPOVEUFNMJGML-UHFFFAOYSA-N 399959 US10323042, Example 39::US10738063, Example 39 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 1260 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399959&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380360 405259993 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943641 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1F InChI=1S/C15H14ClF2N3O2/c1-2-19-14(22)13-12(15-21(20-13)4-3-5-23-15)8-6-11(18)9(16)7-10(8)17/h6-7H,2-5H2,1H3,(H,19,22) MYPOVEUFNMJGML-UHFFFAOYSA-N 399959 US10323042, Example 39::US10738063, Example 39 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 44.0 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399959&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380360 405259993 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943642 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1F InChI=1S/C15H14ClF2N3O2/c1-2-19-14(22)13-12(15-21(20-13)4-3-5-23-15)8-6-11(18)9(16)7-10(8)17/h6-7H,2-5H2,1H3,(H,19,22) MYPOVEUFNMJGML-UHFFFAOYSA-N 399959 US10323042, Example 39::US10738063, Example 39 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 232 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399959&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380360 405259993 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943643 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1F InChI=1S/C15H14ClF2N3O2/c1-2-19-14(22)13-12(15-21(20-13)4-3-5-23-15)8-6-11(18)9(16)7-10(8)17/h6-7H,2-5H2,1H3,(H,19,22) MYPOVEUFNMJGML-UHFFFAOYSA-N 399959 US10323042, Example 39::US10738063, Example 39 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >29300 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399959&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380360 405259993 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943644 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClF2N3O2/c17-11-4-1-8(5-12(11)19)13-14(15(23)20-10-2-3-10)21-22-6-9(18)7-24-16(13)22/h1,4-5,9-10H,2-3,6-7H2,(H,20,23) MKFKTQOJJMIDOC-UHFFFAOYSA-N 399960 US10323042, Example 40::US10738063, Example 40 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 53.2 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399960&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380357 405259994 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943645 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClF2N3O2/c17-11-4-1-8(5-12(11)19)13-14(15(23)20-10-2-3-10)21-22-6-9(18)7-24-16(13)22/h1,4-5,9-10H,2-3,6-7H2,(H,20,23) MKFKTQOJJMIDOC-UHFFFAOYSA-N 399960 US10323042, Example 40::US10738063, Example 40 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 19.7 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399960&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380357 405259994 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943646 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClF2N3O2/c17-11-4-1-8(5-12(11)19)13-14(15(23)20-10-2-3-10)21-22-6-9(18)7-24-16(13)22/h1,4-5,9-10H,2-3,6-7H2,(H,20,23) MKFKTQOJJMIDOC-UHFFFAOYSA-N 399960 US10323042, Example 40::US10738063, Example 40 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 97.3 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399960&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380357 405259994 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943647 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClF2N3O2/c17-11-4-1-8(5-12(11)19)13-14(15(23)20-10-2-3-10)21-22-6-9(18)7-24-16(13)22/h1,4-5,9-10H,2-3,6-7H2,(H,20,23) MKFKTQOJJMIDOC-UHFFFAOYSA-N 399960 US10323042, Example 40::US10738063, Example 40 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 2140 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399960&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380357 405259994 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943648 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-10-3-4-11(12(18)9-10)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AYWBPURWDSSBNA-UHFFFAOYSA-N 399961 US10323042, Example 41::US10738063, Example 41 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 1650 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399961&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380576 405259995 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943649 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-10-3-4-11(12(18)9-10)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AYWBPURWDSSBNA-UHFFFAOYSA-N 399961 US10323042, Example 41::US10738063, Example 41 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 358 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399961&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380576 405259995 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943650 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-10-3-4-11(12(18)9-10)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AYWBPURWDSSBNA-UHFFFAOYSA-N 399961 US10323042, Example 41::US10738063, Example 41 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 918 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399961&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380576 405259995 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943651 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-10-3-4-11(12(18)9-10)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AYWBPURWDSSBNA-UHFFFAOYSA-N 399961 US10323042, Example 41::US10738063, Example 41 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399961&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380576 405259995 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943652 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-9-2-5-11(12(18)8-9)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) IFCNLIRUYVNPKA-UHFFFAOYSA-N 399962 US10323042, Example 42::US10738063, Example 42 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 2050 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399962&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380577 405259996 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943653 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-9-2-5-11(12(18)8-9)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) IFCNLIRUYVNPKA-UHFFFAOYSA-N 399962 US10323042, Example 42::US10738063, Example 42 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 465 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399962&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380577 405259996 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943654 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-9-2-5-11(12(18)8-9)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) IFCNLIRUYVNPKA-UHFFFAOYSA-N 399962 US10323042, Example 42::US10738063, Example 42 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 649 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399962&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380577 405259996 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943655 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-9-2-5-11(12(18)8-9)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) IFCNLIRUYVNPKA-UHFFFAOYSA-N 399962 US10323042, Example 42::US10738063, Example 42 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399962&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380577 405259996 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943656 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22) NXQIEDDZYQXLGS-UHFFFAOYSA-N 399963 US10323042, Example 43::US10738063, Example 43 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 86.2 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399963&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380579 405259997 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943657 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22) NXQIEDDZYQXLGS-UHFFFAOYSA-N 399963 US10323042, Example 43::US10738063, Example 43 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 38.0 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399963&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380579 405259997 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943658 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22) NXQIEDDZYQXLGS-UHFFFAOYSA-N 399963 US10323042, Example 43::US10738063, Example 43 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 174 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399963&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380579 405259997 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943659 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22) NXQIEDDZYQXLGS-UHFFFAOYSA-N 399963 US10323042, Example 43::US10738063, Example 43 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >12600 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399963&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380579 405259997 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943660 Cc1cc(Cl)ccc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23) GRFHQTKEAOBDST-UHFFFAOYSA-N 399964 US10323042, Example 44::US10738063, Example 44 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 55.6 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399964&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380575 405259998 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943661 Cc1cc(Cl)ccc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23) GRFHQTKEAOBDST-UHFFFAOYSA-N 399964 US10323042, Example 44::US10738063, Example 44 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 20.6 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399964&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380575 405259998 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943662 Cc1cc(Cl)ccc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23) GRFHQTKEAOBDST-UHFFFAOYSA-N 399964 US10323042, Example 44::US10738063, Example 44 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 160 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399964&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380575 405259998 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943663 Cc1cc(Cl)ccc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23) GRFHQTKEAOBDST-UHFFFAOYSA-N 399964 US10323042, Example 44::US10738063, Example 44 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 6420 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399964&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380575 405259998 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943664 Fc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-8-9(2-5-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) LGFLTCBFNXDCLY-UHFFFAOYSA-N 399965 US10323042, Example 45::US10738063, Example 45 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 363 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399965&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380578 405259999 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943665 Fc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-8-9(2-5-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) LGFLTCBFNXDCLY-UHFFFAOYSA-N 399965 US10323042, Example 45::US10738063, Example 45 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 64.0 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399965&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380578 405259999 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943666 Fc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-8-9(2-5-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) LGFLTCBFNXDCLY-UHFFFAOYSA-N 399965 US10323042, Example 45::US10738063, Example 45 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 244 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399965&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380578 405259999 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943667 Fc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-8-9(2-5-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) LGFLTCBFNXDCLY-UHFFFAOYSA-N 399965 US10323042, Example 45::US10738063, Example 45 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 2210 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399965&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380578 405259999 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943668 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)NC2CC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-5-4-9(12(18)13(10)19)11-14(15(23)20-8-2-3-8)21-22-6-1-7-24-16(11)22/h4-5,8H,1-3,6-7H2,(H,20,23) FGOAWTXGIORNAM-UHFFFAOYSA-N 399966 US10323042, Example 46::US10738063, Example 46 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 471 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399966&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380580 405260000 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943669 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)NC2CC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-5-4-9(12(18)13(10)19)11-14(15(23)20-8-2-3-8)21-22-6-1-7-24-16(11)22/h4-5,8H,1-3,6-7H2,(H,20,23) FGOAWTXGIORNAM-UHFFFAOYSA-N 399966 US10323042, Example 46::US10738063, Example 46 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 175 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399966&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380580 405260000 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943670 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)NC2CC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-5-4-9(12(18)13(10)19)11-14(15(23)20-8-2-3-8)21-22-6-1-7-24-16(11)22/h4-5,8H,1-3,6-7H2,(H,20,23) FGOAWTXGIORNAM-UHFFFAOYSA-N 399966 US10323042, Example 46::US10738063, Example 46 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 169 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399966&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380580 405260000 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943671 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)NC2CC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-5-4-9(12(18)13(10)19)11-14(15(23)20-8-2-3-8)21-22-6-1-7-24-16(11)22/h4-5,8H,1-3,6-7H2,(H,20,23) FGOAWTXGIORNAM-UHFFFAOYSA-N 399966 US10323042, Example 46::US10738063, Example 46 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 11100 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399966&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380580 405260000 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943672 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)6-8(7-11(13)19)12-14(15(23)20-9-2-3-9)21-22-4-1-5-24-16(12)22/h6-7,9H,1-5H2,(H,20,23) ZDSSYIMMEPTDEO-UHFFFAOYSA-N 399967 US10323042, Example 47::US10738063, Example 47 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 90.0 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399967&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380510 405260001 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943673 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)6-8(7-11(13)19)12-14(15(23)20-9-2-3-9)21-22-4-1-5-24-16(12)22/h6-7,9H,1-5H2,(H,20,23) ZDSSYIMMEPTDEO-UHFFFAOYSA-N 399967 US10323042, Example 47::US10738063, Example 47 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 15.7 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399967&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380510 405260001 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943674 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)6-8(7-11(13)19)12-14(15(23)20-9-2-3-9)21-22-4-1-5-24-16(12)22/h6-7,9H,1-5H2,(H,20,23) ZDSSYIMMEPTDEO-UHFFFAOYSA-N 399967 US10323042, Example 47::US10738063, Example 47 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 45.8 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399967&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380510 405260001 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943675 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)6-8(7-11(13)19)12-14(15(23)20-9-2-3-9)21-22-4-1-5-24-16(12)22/h6-7,9H,1-5H2,(H,20,23) ZDSSYIMMEPTDEO-UHFFFAOYSA-N 399967 US10323042, Example 47::US10738063, Example 47 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 1670 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399967&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380510 405260001 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943676 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17ClFN3O2/c1-10-8-12(18)13(19)9-11(10)14-15(16(23)21-4-2-5-21)20-22-6-3-7-24-17(14)22/h8-9H,2-7H2,1H3 GUBLWTBQTNDNFO-UHFFFAOYSA-N 399968 US10323042, Example 48::US10738063, Example 48 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 65.0 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399968&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380508 405260002 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943677 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17ClFN3O2/c1-10-8-12(18)13(19)9-11(10)14-15(16(23)21-4-2-5-21)20-22-6-3-7-24-17(14)22/h8-9H,2-7H2,1H3 GUBLWTBQTNDNFO-UHFFFAOYSA-N 399968 US10323042, Example 48::US10738063, Example 48 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 12.1 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399968&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380508 405260002 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943678 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17ClFN3O2/c1-10-8-12(18)13(19)9-11(10)14-15(16(23)21-4-2-5-21)20-22-6-3-7-24-17(14)22/h8-9H,2-7H2,1H3 GUBLWTBQTNDNFO-UHFFFAOYSA-N 399968 US10323042, Example 48::US10738063, Example 48 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 63.8 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399968&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380508 405260002 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943679 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17ClFN3O2/c1-10-8-12(18)13(19)9-11(10)14-15(16(23)21-4-2-5-21)20-22-6-3-7-24-17(14)22/h8-9H,2-7H2,1H3 GUBLWTBQTNDNFO-UHFFFAOYSA-N 399968 US10323042, Example 48::US10738063, Example 48 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 706 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399968&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380508 405260002 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943680 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)7-9(8-11(13)19)12-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(12)22/h7-8H,1-6H2 XUMPDYRHXWOEDT-UHFFFAOYSA-N 399969 US10323042, Example 49::US10738063, Example 49 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 111 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399969&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380506 405260003 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943681 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)7-9(8-11(13)19)12-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(12)22/h7-8H,1-6H2 XUMPDYRHXWOEDT-UHFFFAOYSA-N 399969 US10323042, Example 49::US10738063, Example 49 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 13.3 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399969&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380506 405260003 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943682 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)7-9(8-11(13)19)12-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(12)22/h7-8H,1-6H2 XUMPDYRHXWOEDT-UHFFFAOYSA-N 399969 US10323042, Example 49::US10738063, Example 49 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 91.9 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399969&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380506 405260003 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943683 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)7-9(8-11(13)19)12-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(12)22/h7-8H,1-6H2 XUMPDYRHXWOEDT-UHFFFAOYSA-N 399969 US10323042, Example 49::US10738063, Example 49 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 1200 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399969&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380506 405260003 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943684 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-8-11(13(19)7-10(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 HIZORNOKOHJTBO-UHFFFAOYSA-N 399970 US10323042, Example 50::US10738063, Example 50 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 172 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399970&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380511 405260004 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943685 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-8-11(13(19)7-10(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 HIZORNOKOHJTBO-UHFFFAOYSA-N 399970 US10323042, Example 50::US10738063, Example 50 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 40.8 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399970&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380511 405260004 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943686 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-8-11(13(19)7-10(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 HIZORNOKOHJTBO-UHFFFAOYSA-N 399970 US10323042, Example 50::US10738063, Example 50 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 343 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399970&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380511 405260004 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943687 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-8-11(13(19)7-10(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 HIZORNOKOHJTBO-UHFFFAOYSA-N 399970 US10323042, Example 50::US10738063, Example 50 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 12500 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399970&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380511 405260004 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943688 Cc1cc(C#N)c(F)cc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25) CICKNGAWODWCEX-UHFFFAOYSA-N 399971 US10323042, Example 51::US10738063, Example 51 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 26.7 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399971&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380512 405260005 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943689 Cc1cc(C#N)c(F)cc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25) CICKNGAWODWCEX-UHFFFAOYSA-N 399971 US10323042, Example 51::US10738063, Example 51 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 12.0 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399971&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380512 405260005 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943690 Cc1cc(C#N)c(F)cc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25) CICKNGAWODWCEX-UHFFFAOYSA-N 399971 US10323042, Example 51::US10738063, Example 51 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 108 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399971&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380512 405260005 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943691 Cc1cc(C#N)c(F)cc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25) CICKNGAWODWCEX-UHFFFAOYSA-N 399971 US10323042, Example 51::US10738063, Example 51 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 558 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399971&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380512 405260005 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943692 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m1/s1 CICKNGAWODWCEX-LLVKDONJSA-N 399972 US10323042, Example 52::US10738063, Example 52 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 3090 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399972&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380509 405260006 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943693 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m1/s1 CICKNGAWODWCEX-LLVKDONJSA-N 399972 US10323042, Example 52::US10738063, Example 52 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 763 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399972&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380509 405260006 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943694 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m1/s1 CICKNGAWODWCEX-LLVKDONJSA-N 399972 US10323042, Example 52::US10738063, Example 52 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 3020 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399972&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380509 405260006 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943695 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m1/s1 CICKNGAWODWCEX-LLVKDONJSA-N 399972 US10323042, Example 52::US10738063, Example 52 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >25000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399972&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380509 405260006 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943696 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 10.6 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943697 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 5.35 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943698 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 74.7 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943699 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 312 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943700 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 29.2 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943701 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 6.45 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943702 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 75.9 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943703 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 337 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943704 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m0/s1 NXQIEDDZYQXLGS-NSHDSACASA-N 399975 US10323042, Example 54::US10738063, Example 54 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 82.9 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399975&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380481 405260008 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943705 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m0/s1 NXQIEDDZYQXLGS-NSHDSACASA-N 399975 US10323042, Example 54::US10738063, Example 54 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 25.3 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399975&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380481 405260008 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943706 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m0/s1 NXQIEDDZYQXLGS-NSHDSACASA-N 399975 US10323042, Example 54::US10738063, Example 54 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 184 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399975&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380481 405260008 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943707 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m0/s1 NXQIEDDZYQXLGS-NSHDSACASA-N 399975 US10323042, Example 54::US10738063, Example 54 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 8250 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399975&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380481 405260008 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943708 F[C@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m1/s1 NXQIEDDZYQXLGS-LLVKDONJSA-N 399976 US10323042, Example 55::US10738063, Example 55 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 3610 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399976&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380478 405260009 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943709 F[C@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m1/s1 NXQIEDDZYQXLGS-LLVKDONJSA-N 399976 US10323042, Example 55::US10738063, Example 55 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 1850 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399976&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380478 405260009 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943710 F[C@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m1/s1 NXQIEDDZYQXLGS-LLVKDONJSA-N 399976 US10323042, Example 55::US10738063, Example 55 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 3840 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399976&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380478 405260009 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943711 F[C@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m1/s1 NXQIEDDZYQXLGS-LLVKDONJSA-N 399976 US10323042, Example 55::US10738063, Example 55 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >23600 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399976&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380478 405260009 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943712 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m1/s1 DJQNRDCGWWXDHA-SECBINFHSA-N 399977 US10323042, Example 56::US10738063, Example 56 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 796 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399977&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380479 405260010 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943713 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m1/s1 DJQNRDCGWWXDHA-SECBINFHSA-N 399977 US10323042, Example 56::US10738063, Example 56 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 268 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399977&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380479 405260010 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943714 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m1/s1 DJQNRDCGWWXDHA-SECBINFHSA-N 399977 US10323042, Example 56::US10738063, Example 56 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 658 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399977&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380479 405260010 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943715 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m1/s1 DJQNRDCGWWXDHA-SECBINFHSA-N 399977 US10323042, Example 56::US10738063, Example 56 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 14600 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399977&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380479 405260010 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943716 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m0/s1 DJQNRDCGWWXDHA-VIFPVBQESA-N 399978 US10323042, Example 57::US10738063, Example 57 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 5.66 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399978&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 137497759 405260011 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943717 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m0/s1 DJQNRDCGWWXDHA-VIFPVBQESA-N 399978 US10323042, Example 57::US10738063, Example 57 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 1.86 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399978&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 137497759 405260011 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943718 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m0/s1 DJQNRDCGWWXDHA-VIFPVBQESA-N 399978 US10323042, Example 57::US10738063, Example 57 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 28.5 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399978&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 137497759 405260011 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943719 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m0/s1 DJQNRDCGWWXDHA-VIFPVBQESA-N 399978 US10323042, Example 57::US10738063, Example 57 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 136 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399978&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 137497759 405260011 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943720 Cc1cc(Cl)c(F)cc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H15ClF3N3O2/c1-8-4-11(18)12(19)5-10(8)13-14(15(25)22-9-2-3-9)23-24-6-17(20,21)7-26-16(13)24/h4-5,9H,2-3,6-7H2,1H3,(H,22,25) GILOGFJUMQAJNQ-UHFFFAOYSA-N 457828 US10738063, Example 58 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 8.52 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457828&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 155884362 440973515 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943721 Cc1cc(Cl)c(F)cc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H15ClF3N3O2/c1-8-4-11(18)12(19)5-10(8)13-14(15(25)22-9-2-3-9)23-24-6-17(20,21)7-26-16(13)24/h4-5,9H,2-3,6-7H2,1H3,(H,22,25) GILOGFJUMQAJNQ-UHFFFAOYSA-N 457828 US10738063, Example 58 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human 1.000 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457828&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 155884362 440973515 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943722 Cc1cc(Cl)c(F)cc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H15ClF3N3O2/c1-8-4-11(18)12(19)5-10(8)13-14(15(25)22-9-2-3-9)23-24-6-17(20,21)7-26-16(13)24/h4-5,9H,2-3,6-7H2,1H3,(H,22,25) GILOGFJUMQAJNQ-UHFFFAOYSA-N 457828 US10738063, Example 58 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL 16.4 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457828&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 155884362 440973515 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943723 Cc1cc(Cl)c(F)cc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H15ClF3N3O2/c1-8-4-11(18)12(19)5-10(8)13-14(15(25)22-9-2-3-9)23-24-6-17(20,21)7-26-16(13)24/h4-5,9H,2-3,6-7H2,1H3,(H,22,25) GILOGFJUMQAJNQ-UHFFFAOYSA-N 457828 US10738063, Example 58 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 156 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457828&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 155884362 440973515 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943724 Clc1ccc(nc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C15H15ClN4O2/c16-9-2-5-11(17-8-9)12-13(14(21)18-10-3-4-10)19-20-6-1-7-22-15(12)20/h2,5,8,10H,1,3-4,6-7H2,(H,18,21) ZQOTYNLKFJDUAT-UHFFFAOYSA-N 399980 US10323042, Example 59::US10738063, Example 59 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human >30000 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399980&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380515 405260013 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943725 Clc1ccc(nc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C15H15ClN4O2/c16-9-2-5-11(17-8-9)12-13(14(21)18-10-3-4-10)19-20-6-1-7-22-15(12)20/h2,5,8,10H,1,3-4,6-7H2,(H,18,21) ZQOTYNLKFJDUAT-UHFFFAOYSA-N 399980 US10323042, Example 59::US10738063, Example 59 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399980&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380515 405260013 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943726 Cc1cncc(c1)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H18N4O2/c1-11-8-12(10-17-9-11)13-14(15(21)19-4-2-5-19)18-20-6-3-7-22-16(13)20/h8-10H,2-7H2,1H3 QSAFHZCASRDUOV-UHFFFAOYSA-N 399981 US10323042, Example 60::US10738063, Example 60 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human >28928 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399981&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380514 405260014 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943727 Cc1cncc(c1)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H18N4O2/c1-11-8-12(10-17-9-11)13-14(15(21)19-4-2-5-19)18-20-6-3-7-22-16(13)20/h8-10H,2-7H2,1H3 QSAFHZCASRDUOV-UHFFFAOYSA-N 399981 US10323042, Example 60::US10738063, Example 60 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399981&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380514 405260014 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943728 FC(F)(F)c1cncc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15F3N4O2/c17-16(18,19)10-6-9(7-20-8-10)12-13(14(24)21-11-2-3-11)22-23-4-1-5-25-15(12)23/h6-8,11H,1-5H2,(H,21,24) BJUFTSVFKDFZEX-UHFFFAOYSA-N 399982 US10323042, Example 61::US10738063, Example 61 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human >30000 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399982&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380513 405260015 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943729 FC(F)(F)c1cncc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15F3N4O2/c17-16(18,19)10-6-9(7-20-8-10)12-13(14(24)21-11-2-3-11)22-23-4-1-5-25-15(12)23/h6-8,11H,1-5H2,(H,21,24) BJUFTSVFKDFZEX-UHFFFAOYSA-N 399982 US10323042, Example 61::US10738063, Example 61 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human 30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399982&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380513 405260015 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943730 Cc1ccc(cc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-3-4-12(10-19)9-14(11)15-16(17(23)20-13-5-6-13)21-22-7-2-8-24-18(15)22/h3-4,9,13H,2,5-8H2,1H3,(H,20,23) ZVWGRJASDAIIGJ-UHFFFAOYSA-N 399983 US10323042, Example 62::US10738063, Example 62 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human 16556 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399983&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380516 405260016 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943731 Cc1ccc(cc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-3-4-12(10-19)9-14(11)15-16(17(23)20-13-5-6-13)21-22-7-2-8-24-18(15)22/h3-4,9,13H,2,5-8H2,1H3,(H,20,23) ZVWGRJASDAIIGJ-UHFFFAOYSA-N 399983 US10323042, Example 62::US10738063, Example 62 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399983&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380516 405260016 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943732 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(cc1F)C#N InChI=1S/C17H17FN4O2/c1-10(2)20-16(23)15-14(17-22(21-15)6-3-7-24-17)12-5-4-11(9-19)8-13(12)18/h4-5,8,10H,3,6-7H2,1-2H3,(H,20,23) KKPVIUOWNKMGHX-UHFFFAOYSA-N 399984 US10323042, Example 63::US10738063, Example 63 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human >22462 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399984&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380457 405260017 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943733 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(cc1F)C#N InChI=1S/C17H17FN4O2/c1-10(2)20-16(23)15-14(17-22(21-15)6-3-7-24-17)12-5-4-11(9-19)8-13(12)18/h4-5,8,10H,3,6-7H2,1-2H3,(H,20,23) KKPVIUOWNKMGHX-UHFFFAOYSA-N 399984 US10323042, Example 63::US10738063, Example 63 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human >30000 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399984&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380457 405260017 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943734 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(cc1F)C#N InChI=1S/C17H17FN4O2/c1-10(2)20-16(23)15-14(17-22(21-15)6-3-7-24-17)12-5-4-11(9-19)8-13(12)18/h4-5,8,10H,3,6-7H2,1-2H3,(H,20,23) KKPVIUOWNKMGHX-UHFFFAOYSA-N 399984 US10323042, Example 63::US10738063, Example 63 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL >30000 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399984&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380457 405260017 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943735 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(cc1F)C#N InChI=1S/C17H17FN4O2/c1-10(2)20-16(23)15-14(17-22(21-15)6-3-7-24-17)12-5-4-11(9-19)8-13(12)18/h4-5,8,10H,3,6-7H2,1-2H3,(H,20,23) KKPVIUOWNKMGHX-UHFFFAOYSA-N 399984 US10323042, Example 63::US10738063, Example 63 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399984&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380457 405260017 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 943736 CNC(=O)c1nn2CCCOc2c1-c1ccc(OC(F)F)nc1 InChI=1S/C14H14F2N4O3/c1-17-12(21)11-10(13-20(19-11)5-2-6-22-13)8-3-4-9(18-7-8)23-14(15)16/h3-4,7,14H,2,5-6H2,1H3,(H,17,21) AJJQMMGWFICENJ-UHFFFAOYSA-N 399985 US10323042, Example 64::US10738063, Example 64 cAMP-specific 3',5'-cyclic phosphodiesterase 4B [122-736] Human >21604 US Patent 10.7270/Q20Z76BW aid1804691 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=901&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399985&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%5B122-736%5D&column=ki&startPg=0&Increment=50&submit=Search 130380456 405260018 1 ATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 943737 CNC(=O)c1nn2CCCOc2c1-c1ccc(OC(F)F)nc1 InChI=1S/C14H14F2N4O3/c1-17-12(21)11-10(13-20(19-11)5-2-6-22-13)8-3-4-9(18-7-8)23-14(15)16/h3-4,7,14H,2,5-6H2,1H3,(H,17,21) AJJQMMGWFICENJ-UHFFFAOYSA-N 399985 US10323042, Example 64::US10738063, Example 64 cAMP-specific 3',5'-cyclic phosphodiesterase 4A [2-825] Human >27309 US Patent 10.7270/Q20Z76BW aid1804692 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=899&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399985&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A+%5B2-825%5D&column=ki&startPg=0&Increment=50&submit=Search 130380456 405260018 1 EPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWR 2QYK,3I8V,3TVX cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A_HUMAN P27815 O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2 943738 CNC(=O)c1nn2CCCOc2c1-c1ccc(OC(F)F)nc1 InChI=1S/C14H14F2N4O3/c1-17-12(21)11-10(13-20(19-11)5-2-6-22-13)8-3-4-9(18-7-8)23-14(15)16/h3-4,7,14H,2,5-6H2,1H3,(H,17,21) AJJQMMGWFICENJ-UHFFFAOYSA-N 399985 US10323042, Example 64::US10738063, Example 64 cAMP-specific 3',5'-cyclic phosphodiesterase 4C [2-712] NULL >30000 US Patent 10.7270/Q20Z76BW aid1804693 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=903&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399985&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C+%5B2-712%5D&column=ki&startPg=0&Increment=50&submit=Search 130380456 405260018 1 ENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT 2PW3,2QYM,5K32 cAMP-specific 3',5'-cyclic phosphodiesterase 4C PDE4C_HUMAN Q08493 B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6 943739 CNC(=O)c1nn2CCCOc2c1-c1ccc(OC(F)F)nc1 InChI=1S/C14H14F2N4O3/c1-17-12(21)11-10(13-20(19-11)5-2-6-22-13)8-3-4-9(18-7-8)23-14(15)16/h3-4,7,14H,2,5-6H2,1H3,(H,17,21) AJJQMMGWFICENJ-UHFFFAOYSA-N 399985 US10323042, Example 64::US10738063, Example 64 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 0-562] Human >30000 US Patent 10.7270/Q20Z76BW aid1804694 US10738063 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM 8/11/2020 4/4/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=904&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399985&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29+0-562%5D&column=ki&startPg=0&Increment=50&submit=Search 130380456 405260018 1 QRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7